Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#Artificial Intelligence In Pathology Market Forecast: Value Set To Climb From $1.57 Billion To $2.57 Billion#_x000D_
In recent years, the artificial intelligence in pathology market has experienced rapid expansion. The market is anticipated to grow from $1.38 billion in 2025 to $1.57 billion in 2026, showing a compound annual growth rate (CAGR) of 13.4%. This historical growth can be attributed to the increasing digitization of pathology workflows, a rising demand for accurate cancer diagnostics, the expansion of pharmaceutical research activities, the adoption of digital slide scanners, and the growing availability of medical imaging datasets._x000D_
_x000D_
The artificial intelligence in pathology market size is expected to witness rapid expansion in the next few years. It will grow to $2.57 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. This anticipated growth during the forecast period is driven by factors such as the increasing deployment of AI-assisted diagnostics, a rising emphasis on personalized medicine, the broader integration of AI in clinical decision support, growing investments into digital healthcare infrastructure, and an increase in regulatory approvals for AI-based pathology tools. Key trends emerging in the forecast period include the increasing adoption of AI-based digital pathology platforms, a rise in the use of deep learning for tumor detection, the growing incorporation of whole slide imaging systems, the expansion of predictive analytics in disease diagnosis, and an enhanced focus on workflow automation within pathology laboratories._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Artificial Intelligence In Pathology Market Growth Drivers: What’s Behind The Acceleration?#_x000D_
The escalating requirement for personalized medicine is projected to stimulate the expansion of the artificial intelligence in pathology market moving forward. Personalized medicine involves customizing medical treatment and healthcare services to align with the distinct characteristics, needs, and preferences of each patient. The increasing demand for personalized medicine arises from its capacity to tailor therapies to individual genetic profiles, lifestyle aspects, and specific disease attributes, thereby enhancing effectiveness and reducing adverse reactions. Artificial intelligence (AI) in pathology assists personalized medicine by enabling more precise and efficient analysis of medical images and genetic data, which facilitates more accurate diagnoses, better identification of disease subtypes, and customized treatment plans that correspond to an individual’s unique biological make-up. For instance, in February 2024, as per the Personalized Medicine Coalition (PMC), a US-based professional membership organisation, the US Food and Drug Administration (FDA) approved 20 new personalized medicines in 2023. This accounted for approximately 38% of all newly approved therapeutic molecular entities, indicating a notable increase compared to prior years. Hence, the rising need for personalized medicine is propelling the growth of the artificial intelligence in pathology market._x000D_
_x000D_
#Artificial Intelligence In Pathology Market Segments: Where Is Growth Concentrated?#_x000D_
The artificial intelligence in pathology market covered in this report is segmented – _x000D_
_x000D_
1) By Component: Software, Scanners_x000D_
2) By Neural Network: Generative Adversarial Networks, Convolutional Neural Networks, Conventional Neural Network, Recurrent Neural Networks, Other Neural Networks_x000D_
3) By Application: Drug Discovery, Disease Diagnosis And Prognosis, Clinical Workflow, Training And Education_x000D_
4) By End User: Pharmaceutical And Biotechnology Companies, Hospitals And Reference Laboratories, Academic And Research Institutes_x000D_
_x000D_
Subsegments:_x000D_
1) By Software: Image Analysis Software, Diagnostic Workflow Software, Predictive Analytics Software_x000D_
2) By Scanners: Whole Slide Imaging Scanners, Digital Pathology Scanners, Multi-Spectral Imaging Scanners_x000D_
_x000D_
#Artificial Intelligence In Pathology Market Trends: What’s Defining The Industry’s Next Phase?#_x000D_
Companies active in the artificial intelligence (AI) in pathology market are concentrating on creating advanced solutions, particularly multi-tissue cancer detection tools, to improve diagnostic precision, optimize workflows, and achieve better patient outcomes. These AI-powered multi-tissue cancer detection tools employ foundation models and deep learning algorithms to examine digitized pathology slides, allowing for detection across diverse tissue types, including unusual tumors and metastatic formations. For example, in January 2024, Paige, a US-based digital pathology company, introduced a new AI application built on its Virchow foundation model, which is capable of detecting cancer across more than 17 distinct tissue types. This solution is intended to support pathologists by providing enhanced diagnostic accuracy, more rapid workflow efficiency, and practical insights for individualized patient care._x000D_
_x000D_
#Artificial Intelligence In Pathology Market Key Participants And Competitive Landscape#_x000D_
Major companies operating in the artificial intelligence in pathology market are F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Hamamatsu Photonics K.K., Leica Biosystems, Tempus Labs Inc., Spectra AB, Lunit Inc., Paige AI Inc., Inspirata Inc., Indica Labs Inc., Flagship Biosciences Inc, Proscia Inc., Aiforia Technologies Oy, Lumea Inc., Optrascan Inc., PathAI Inc., Visiopharm A/S, Ibex Medical Analytics Ltd., BioSymetrics Inc., Deep Bio Inc., Konfoong Biotech International Co Ltd., Mindpeak GmbH, Qritive Inc., Vuno Inc. _x000D_
_x000D_
#View The Full Artificial Intelligence In Pathology Market Report:#_x000D_
_x000D_
#Artificial Intelligence In Pathology Market Geographic Analysis: Where Is Demand Rising Fastest?#_x000D_
Asia-Pacific was the largest region in the artificial intelligence in pathology market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in pathology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
